癌症中的"热TRP"通道表达:诊断和预后的影响 (病理学家的实践方法)
1Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
International journal of molecular sciences
|May 27, 2023
概括
癌症中温度敏感的短暂受体潜能 (TRP) 通道或热TRP的改变表达可能有助于诊断和预后. 热TRP表达可以区分良性病变和恶性病变,并预测患者的结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞信号传递 细胞信号传递
背景情况:
- 温度敏感的短暂受体潜能 (TRP) 通道,或热TRP,是参与细胞生长和分化的关键信号分子.
- 在各种癌症中观察到热TRP通道的改变表达,但其作为原因或后果的作用仍在调查中.
研究的目的:
- 审查目前对癌症中热TRP通道表达的理解.
- 探索热TRP表达作为瘤学诊断和预后生物标志物的潜力.
- 为病理学家强调基于热TRP的免疫蛋白的实用性.
主要方法:
- 对不同癌症类型中研究热TRP通道表达的研究进行文献综述.
- 对热TRP表达与癌症诊断,预后和治疗反应之间的相关性现有数据的分析.
- 专注于免疫组织化学的应用,以检测临床环境中的热TRP表达.
主要成果:
- 在良性和恶性病变之间,热TRP表达模式不同 (例如,胃癌和泌尿器癌中的TRPV1).
- 特定的热TRP表达与临床结果相关 (例如,前列腺癌中的TRPM8预测了侵袭性疾病).
- 热TRP表达 (例如,TRPV1) 可以识别肺腺癌中预后不佳和化疗耐药性的患者子组.
结论:
- 变化的热TRP表达代表了癌症诊断和预后的潜在生物标志物.
- 热TRP表达分析,特别是通过免疫染色,为病理学家在诊断和管理癌症方面提供了宝贵的见解.
- 对热TRP通道的进一步研究可能会导致瘤学中新的诊断和治疗策略.
更多相关视频
06:19Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
3.2K
10:23Author Spotlight: Computing the Effects of a Local Radiofrequency Hyperthermia Intervention on Tumor Biomechanics
Published on: December 1, 2023
488
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer-Critical Genes I: Proto-oncogenes
9.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
